Study Comparing GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses
Status:
Completed
Trial end date:
2017-09-06
Target enrollment:
Participant gender:
Summary
This research study is being done to compare the safety and effectiveness of GDC 695 (test
drug) against the currently marketed reference drug (diclofenac sodium gel, 3%) and to
establish that these two drugs work better than placebo in the treatment of actinic
keratosis.